Karjalainen, Marjo J., Pertti J. Neuvonen, and Janne T. Backman.
"Rofecoxib Is a Potent, Metabolism-Dependent Inhibitor of CYP1A2: Implications for in Vitro Prediction of Drug Interactions." Drug Metabolism and Disposition
34.12
(2006):
2091-2096.
Web. 19 April. 2024.